# A Study of the Neurological Effects of Adding Maraviroc to HAART Regimen in Patients With HIV (HANDmac)

> **NCT01449006** · PHASE4 · COMPLETED · sponsor: **Bruce Brew** · enrollment: 19 (actual)

## Conditions studied

- Human Immunodeficiency Virus (HIV)
- HIV Associated Neurocognitive Disorders (HAND)

## Interventions

- **DRUG:** Maraviroc

## Key facts

- **NCT ID:** NCT01449006
- **Lead sponsor:** Bruce Brew
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2019-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01449006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01449006, "A Study of the Neurological Effects of Adding Maraviroc to HAART Regimen in Patients With HIV (HANDmac)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01449006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*